Teenage mutant neutrophilic precursors: Leukemia cutis with IDH2 mutation on enasidenib therapy

被引：4
|
作者：
Kallen, Michael E. [1 ]
Koka, Rima [1 ]
Singh, Zeba [1 ]
Sanchez-Petitto, Gabriela [2 ]
Zaman, Qamar U. [3 ]
Yared, Jean A. [2 ]
Duong, Vu H. [2 ]
机构：
[1] Univ Maryland, Sch Med, Dept Pathol, 22 S Greene St,NBW-54, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, Div Hematol Oncol, Baltimore, MD 21201 USA
[3] Univ Pittsburgh, Med Ctr, Western Maryland, Cumberland, MD USA
来源：
LEUKEMIA RESEARCH | 2020年 / 96卷
关键词：
DIFFERENTIATION SYNDROME;
D O I：
10.1016/j.leukres.2020.106406
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation
    Geoerger, Birgit
    Schiff, Manuel
    Penard-Lacronique, Virginie
    Darin, Niklas
    Saad, Selim-Maria
    Duchon, Clarisse
    Lamaziere, Antonin
    Desmons, Aurore
    Pontoizeau, Clement
    Berlanga, Pablo
    Ducassou, Stephane
    Yen, Katharine
    Su, Michael
    Schenkein, David
    Ottolenghi, Chris
    De Botton, Stephane
    NATURE MEDICINE, 2023, 29 (06) : 1358 - +
  • [22] NPMC COOPERATES WITH MUTANT IDH2 TO INDUCE ACUTE MYELOID LEUKEMIA
    Ogawara, Yoko
    Katsumoto, Takuo
    Aikawa, Yukiko
    Kagiyama, Yuki
    Kitabayashi, Issay
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S55 - S55
  • [23] Inhibitors of mutant IDH1 and IDH2
    Pamela Feliciano
    Nature Genetics, 2013, 45 (5) : 477 - 477
  • [24] Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation
    Birgit Geoerger
    Manuel Schiff
    Virginie Penard-Lacronique
    Niklas Darin
    Selim-Maria Saad
    Clarisse Duchon
    Antonin Lamazière
    Aurore Desmons
    Clément Pontoizeau
    Pablo Berlanga
    Stéphane Ducassou
    Katharine Yen
    Michael Su
    David Schenkein
    Chris Ottolenghi
    Stéphane De Botton
    Nature Medicine, 2023, 29 : 1358 - 1363
  • [25] Induction of sarcomas by mutant IDH2
    Lu, Chao
    Venneti, Sriram
    Akalin, Altuna
    Fang, Fang
    Ward, Patrick S.
    DeMatteo, Raymond G.
    Intlekofer, Andrew M.
    Chen, Chong
    Ye, Jiangbin
    Hameed, Meera
    Nafa, Khedoudja
    Agaram, Narasimhan P.
    Cross, Justin R.
    Khanin, Raya
    Mason, Christopher E.
    Healey, John H.
    Lowe, Scott W.
    Schwartz, Gary K.
    Melnick, Ari
    Thompson, Craig B.
    GENES & DEVELOPMENT, 2013, 27 (18) : 1986 - 1998
  • [26] The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia
    Nassereddine, Samah
    Lap, Coen J.
    Haroun, Faysal
    Tabbara, Imad
    ANNALS OF HEMATOLOGY, 2017, 96 (12) : 1983 - 1991
  • [27] The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia
    Samah Nassereddine
    Coen J. Lap
    Faysal Haroun
    Imad Tabbara
    Annals of Hematology, 2017, 96 : 1983 - 1991
  • [28] Enasidenib-Induced Differentiation Syndrome in IDH2-Mutant Acute Myeloid Leukemia
    Patel, Shyam A.
    JAMA ONCOLOGY, 2018, 4 (08) : 1110 - +
  • [29] Acute Myeloid Leukemia With IDH1 or IDH2 Mutation Frequency and Clinicopathologic Features
    Patel, Keyur P.
    Ravandi, Farhad
    Ma, Deqin
    Paladugu, Abhaya
    Barkoh, Bedia A.
    Medeiros, L. Jeffrey
    Luthra, Rajyalakshmi
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (01) : 35 - 45
  • [30] IDH2 R140Q mutation associated with palisaded neutrophilic and granulomatous dermatitis with subsequent development of IDH2-mutated acute myeloid leukemia
    Himed, Sonia
    Chung, Catherine
    Jones, Dan
    Wall, Sarah
    Kaffenberger, Benjamin H.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (04) : E217 - E219
12345